Pyxis Oncology share price logo

Pyxis Oncology

NASDAQ: PYXS

$1.69

-0.12

(-6.63%)

as on

Pyxis Oncology Stock Performance

as on November 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.62
    $1.86
    downward going graph

    4.14%

    Downside

    10.06%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.03
    $5.55
    downward going graph

    39.05%

    Downside

    228.40%

    Upside

    downward going graph

Pyxis Oncology share price movements today

Previous Close
$1.81
Open
$1.82
Volume
1.1M
Market Cap
$216.2M
Day's Low - High
$1.62 - $1.86
52 Week Low - High
$1.03 - $5.55

Pyxis Oncology Historical Returns

1 Month Return
-21.03 %
3 Month Return
-44.41 %
1 Year Return
-55.64 %
3 Year Return
-3.98 %
5 Year Return
-87.55 %

Pyxis Oncology Stock Fundamentals & Key Indicators

Check Pyxis Oncology market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$216.2M

EPS (TTM)

-1.41

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.28

Industry PE ratio

-3.13

PEG Ratio

-0.17

EBITDA

-83.4M

Revenue (TTM)

11.0M

Profit Margin

99.76%

Return On Equity TTM

-215.23%

Pyxis Oncology vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pyxis Oncology with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$216.2M-87.55%-1.2899.76%0.00%
Neutral$88.5B-36.16%-27.78-12.57%0.00%
StrongBuy$141.7B192.56%32.2786.04%0.00%
Buy$95.5B47.41%19.7685.77%0.40%

Stock Returns calculator for Pyxis Oncology Stock including INR - Dollar returns

The Pyxis Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pyxis Oncology investment value today

Current value as on today

₹47,445

Returns

-₹52,555

(-52.56%)

Returns from Pyxis Oncology Stock

-₹55,643 (-55.64%)

Dollar Impact

₹3,088 (+3.09%)

Analyst Recommendation on Pyxis Oncology Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71428571428571% of analysts recommend a 'BUY' rating for Pyxis Oncology. Average target price of $8.88

Pyxis Oncology Share Price Target

Get share price movements and forecasts by analysts on Pyxis Oncology.

What analysts predicted

80.97%UPSIDE

Target Price

$8.88

Current Price

$1.69

Analyzed by

7 Analysts

High

$19

Target

$8.88

Low

$6

Pyxis Oncology target price $8.88, a slight upside of 80.97% compared to current price of $1.69. According to 7 analysts rating.

Indian Investors' Interest in Pyxis Oncology Stock

Search interest for Pyxis Oncology Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

Pyxis Oncology Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
16
-
-
-
-
2
-
11
-
-
Gross Profit
15
-
-
-
-
2
-
11
0
-
Operating Income
-5
-20
-23
-40
-22
-19
-23
-18
-24
-25
EBITDA
-2
-16
-20
-18
-20
-17
-21
-14
-22
-25
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
1
0
0
0
0
0
0
2
0
0
Income Before Tax
-3
-17
-21
-37
-21
-18
-22
-17
-23
-25
Income Tax Expense
-
-
-
-2
-
0
-
1
-
-
Net Income
-3
-17
-21
-35
-21
-18
-22
-18
-23
-25
Net Profit Margin
97.06%
0.00%
0.00%
0.00%
0.00%
100.00%
0.00%
103.91%
0.00%
0.00%

Pyxis Oncology Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
16
13
Gross Profit
-
0
-
-
-
15
11
Operating Income
-2
-12
-69
-123
-82
-89
-84
EBITDA
-2
-12
-75
-120
-71
-65
-73
Interest Expense
-
-
-
-
-
-
-
Depreciation
-
0
0
0
1
2
4
Income Before Tax
-2
-12
-75
-120
-73
-79
-78
Income Tax Expense
-
-
-
-
-
-2
1
Net Income
-2
-12
-75
-120
-73
-77
-79
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
97.06%
82.77%

Pyxis Oncology Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-17
-21
-35
-21
-18
-22
-18
-23
-25
Operating Cash Flow
-20
-3
-14
-19
-22
-17
-13
-10
-26
-18
Investing Cash Flow
-18
0
0
26
15
15
11
16
16
21
Financing Cash Flow
57
0
1
0
-
0
0
0
0
9
Change in Cash
18
-2
-13
7
-6
-2
-1
6
-9
13

Pyxis Oncology Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
-12
-75
-120
-73
-77
-79
Operating Cash Flow
-2
-10
-35
-89
-70
-57
-63
Investing Cash Flow
-
-1
0
-6
-104
8
58
Financing Cash Flow
21
0
304
0
5
59
0
Change in Cash
19
-11
268
-95
-169
9
-4

Global Institutional Holdings in Pyxis Oncology

Check out the Institutions with significant holdings in Pyxis Oncology.

Funds
Holdings
GordonMD Global Investments LP
13.00%
Vanguard
3.28%
VANGUARD INDEX FUNDS
1.66%
BlackRock, Inc.
0.73%
iShares
0.69%

Pyxis Oncology News & Key Events

  • img

    Today's Timeline - 02 October

    Fri, 04:30 PM

    -

    Pyxis Oncology closes public offering, generating approximately $110 million in upfront gross proceeds, with potential total proceeds of $282.6 million.

Insights on Pyxis Oncology

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 184.8% return, outperforming this stock by 188.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 786.5% return, outperforming this stock by 842.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PYXS stock has moved down by -8.2%

About Pyxis Oncology

Pyxis Oncology, Inc. operates as a preclinical biopharmaceutical company focused on developing novel therapeutic approaches to combat various forms of cancer. Its investigational immune-oncology pipeline includes PYX-106, a fully human immunoglobulin G1 (IgG1) antibody designed to target siglec-15, which is being explored for its potential efficacy against thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors. Additionally, PYX-102 is an immune-therapeutic currently under investigation for the treatment of solid tumors. The company's portfolio also features a range of investigational antibody-drug conjugate (ADC) candidates: PYX-201, a novel ADC being developed for NSCLC, breast cancer, and other solid tumors; PYX-202, another novel ADC aimed at small cell lung cancer (SCLC), soft tissue sarcoma, and other solid tumors; and PYX-203, an ADC undergoing evaluation for acute myeloid leukemia and myeloid dysplastic syndrome. Pyxis Oncology was founded in 2018 and is based in Cambridge, Massachusetts.
OrganisationPyxis Oncology
Headquarters321 Harrison Avenue, Boston, MA, 02118, US
IndustryBiotechnology
CEOThomas Civik

Key Management of Pyxis Oncology

Name

Title

Dr. Charles T. Gombar Ph.D.

Senior Vice President of Portfolio & Program Management

Dr. Michael Bui

Senior Vice President of Global Regulatory Affairs

Dr. Hongwei Wang M.D., Ph.D.

Head of ADC Development & Clinical Strategy

Dr. Marsha Crochiere Ph.D.

Head of Translational Medicine & Research

Mr. Stan Szpindor

Head of R&D Quality

Mr. Thomas Civik

CEO & Chairman

Dr. Balu N. Balasubramanian Ph.D.

Interim Chief Technology Officer

Donna Regalado

Head of Human Resources

Dr. Supriya Roth Ph.D.

Head of Commercial Development

Dr. Shui He Ph.D.

Head of Biometrics

FAQs

What is Pyxis Oncology share price today?

Pyxis Oncology share price today is $1.69 as on at the close of the market. Pyxis Oncology share today touched a day high of $1.86 and a low of $1.62.

What is the 52 week high and 52 week low for Pyxis Oncology share?

Pyxis Oncology share touched a 52 week high of $5.55 on and a 52 week low of $1.03 on . Pyxis Oncology stock price today i.e. is closed at $1.69,which is 69.55% down from its 52 week high and 64.08% up from its 52 week low.

What is Pyxis Oncology's market capitalisation today?

Pyxis Oncology market capitalisation is $0.00T as on .

How to invest in Pyxis Oncology Stock (PYXS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pyxis Oncology on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Pyxis Oncology Stock (PYXS) from India?

Indian investors can start investing in Pyxis Oncology (PYXS) shares with as little as ₹94.9000015258789 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in Pyxis Oncology stock (as per the Rupee-Dollar exchange rate as on ). Based on Pyxis Oncology share’s latest price of $1.69 as on November 3, 2026 at 8:45 am IST, you will get 5.9172 shares of Pyxis Oncology. Learn more about fractional shares .

What are the returns that Pyxis Oncology has given to Indian investors in the last 5 years?

Pyxis Oncology stock has given -87.55% share price returns and 27.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?